课题基金 / 基金详情

APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS

APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS
载脂蛋白A-I基因多态性与动脉粥样硬化
批准号:
3348940
负责人:
ERNST JOHN SCHAEFER
金额:
$11.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-12-01 至 1988-11-30

项目摘要

项目成果

ERNST JOHN SCHAEFER的其他基金

相似基金

相关文献

中文摘要
翻译
载脂蛋白(apo) A-I是血浆高的主要蛋白质成分
英文摘要
Apolipoprotein (apo) A-I is the major protein constituent of plasma high density lipoproteins (HDL). HDL has been shown to promote cholesterol efflux from cells in vitro. Decreased plasma concentrations of HDL cholesterol and apoA-I have been associated with premature coronary artery disease (CAD) due to atherosclerosis in our society. Genetic HDL deficiency (familial hypoalphalipoproteinemia) appears to be fairly common in patients with premature CAD. The gene for apoA-I has been isolated and characterized. Our preliminary studies indicate that a specific apoA-I gene polymorphism, detected following Pst I restriction enzyme digestion utilizing a specific probe, is significantly more common in subjects with premature CAD (32.8%) than in normal control subjects (3.9%), and in some kindreds is associated with genetic HDL deficiency. This apoA-I gene polymorphism is due to an alteration in the apoA-I, apoC-III intergenic region, near the 3' end of the coding region for ApoA-I. Our specific aims are: 1) to determine the prevalence of genetic HDL cholesterol and apoA-I deficiency and the Pst I apoA-I gene polymorphism in patients with premature CAD and their first degree relatives utilizing standard lipid analysis, immunoassay and Southern blotting; 2) to assess whether the risk of developing premature CAD is associated with the gene polymorphism; 3) to ascertain the relationship between HDL deficiency, the Pst I gene polymorphism, and premature CAD by linkage analysis; 4) to isolate and characterize the abnormal apoA-I, apoC-III gene complex by gene mapping studies with multiple restriction enzymes, and by cloning and sequencing methods. These studies will allow us to test the following hypotheses: 1. The Pst I apoA-I gene polymorphism is associated with genetic HDL deficiency and premature CAD; 2. Genetic HDL deficiency associated with the Pst I apoA-I gene polymorphism is a common familial lipoprotein disorder in patients with premature CAD; 3. The Pst I apoA-I gene polymorphism is due to a specific mutation in the apoA-I, apoC-III intergenic region, which directly or indirectly (via a linked polymorphism) affects apoA-I synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core--Laboratory and Data Management
EFFECTS OF EXTENDED-RELEASE NIACIN ON A COMBINATION OF LOVASTATIN
  • 批准号:
    7200872
  • 项目类别:
  • 资助金额:
    $0.77万
  • 财政年份:
    2005
  • 负责人:
    ERNST JOHN SCHAEFER
  • 依托单位:
Effects of Extended-Release Niacin on a Combination
  • 批准号:
    7040665
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    2004
  • 负责人:
    ERNST JOHN SCHAEFER
  • 依托单位:
Effects of Atorvastatin on the Kinetics of APO B-100
  • 批准号:
    7040659
  • 项目类别:
  • 资助金额:
    $0.47万
  • 财政年份:
    2004
  • 负责人:
    ERNST JOHN SCHAEFER
  • 依托单位:
海外基金